By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous uncategorized agents > Onasemnogene abeparvovec (zolgensma)
Miscellaneous uncategorized agents

Onasemnogene abeparvovec (zolgensma)

https://themeditary.com/drug/onasemnogene-abeparvovec-zolgensma-5239.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 11, 2023  Additional Content by TheMediTary.Com

Generic name: onasemnogene abeparvovec (zolgensma) [ on-a-sem-noe-jeen-a-be-par-voe-vek ]

Drug class: Miscellaneous uncategorized agents

Dosage form: intravenous kit (xioi 20 trillion vg/ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Zolgensma

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Onasemnogene abeparvovec (zolgensma)?

Onasemnogene abeparvovec is used to treat spinal muscular atrophy in children younger than 2 years old who have a specific gene mutation that affects nerve signals to the muscles.

onasemnogene abeparvovec may not be effective in a child who is completely paralyzed or is dependent on a ventilator for breathing.

Onasemnogene abeparvovec may also be used for purposes not listed in this medication guide.

Warnings

onasemnogene abeparvovec can cause serious liver damage, especially in children who already have liver problems. Your doctor will perform blood tests to make sure your child does not have conditions that would make it unsafe to receive onasemnogene abeparvovec.

How should I take Onasemnogene abeparvovec (zolgensma)

Your doctor will perform blood tests to make sure your child does not have conditions that would make it unsafe to receive onasemnogene abeparvovec.

Onasemnogene abeparvovec is given as an infusion into a vein, usually only one time. A healthcare provider will give your child this injection.

onasemnogene abeparvovec must be given slowly, and the infusion can take about 1 hour to complete.

Your child may be given steroid medication to help prevent serious side effects of onasemnogene abeparvovec. Keep giving your child the steroid for as long as your doctor has prescribed. The doctor may gradually reduce the dose as your child continues taking the steroid.

Your child will need frequent blood tests to check his or her liver function.

Your child may need to be vaccinated against respiratory syncytial (sin-SISH-ul) virus, or RSV. Follow the doctor's instructions about this vaccination.

If your child vomits shortly after taking the steroid medicine, do not take another dose. Call the doctor for instructions.

Dosing information

Usual Pediatric Dose for Spinal Muscular Atrophy:

Prior to infusion:
-Assess liver function by clinical examination and laboratory testing (ALT, AST, total bilirubin, and prothrombin time)
-Obtain creatinine, complete blood count (including hemoglobin and platelet counts), and troponin-I
-Assess for the presence of anti-AAV9 antibodies

Corticosteroid
-Initiate systemic corticosteroids 1 day prior to IV infusion and continue for a total of 30 days (equivalent to oral prednisolone 1 mg/kg/day)

Single-dose: 1.1 x 10(14) vector genomes/kg IV through a venous catheter over 60 minutes

Comments:
-See Other comments/Administration advice for guidance on administration; the manufacturer's product labeling provides a dose table which includes dose volume (mL) based on weight.
-The use in patients with advance spinal muscular atrophy (e.g., complete paralysis of limbs, permanent ventilator-dependence) has not been evaluated.
-The safety and effectiveness of repeat administration have not been evaluated.

Use: For the treatment of patients less than 2 years with spinal muscular atrophy with bi-allelic mutations in the survival motor neuron 1 gene; because concomitant treatment with corticosteroids may adversely affect neurological development, infusion should be delayed until corresponding full-term gestational age is reached.

Detailed Onasemnogene abeparvovec dosage information
Onasemnogene abeparvovec (zolgensma) Dosage information (more detail)

Before Taking

This medicine can cause serious liver damage. Tell your doctor if your child has ever had liver problems.

It may not be safe to breastfeed your child while he or she is receiving this medicine. Ask your doctor about any risk.

What happens if I miss a dose?

Onasemnogene abeparvovec is used as a single dose and does not have a daily dosing schedule.

What happens if I overdose?

Since onasemnogene abeparvovec is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using Onasemnogene abeparvovec (zolgensma)?

If your child is also taking steroid medicine, the child should not receive certain vaccines. If your child is due for any vaccine, ask your doctor first before your child gets the shot(s).

Onasemnogene abeparvovec can pass into your child's stools (bowel movements). For at least 1 month after your child receives a dose, avoid allowing the child's stools to come into contact with hands or other surfaces. Wear rubber gloves while cleaning up the child's body fluids, handling contaminated trash or laundry, or changing diapers. Seal used diapers in disposable bags and throw them into the trash. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.

Onasemnogene abeparvovec (zolgensma) side effects

Get emergency medical help if your child has signs of an allergic reaction: hives; difficult breathing; swelling of the face, lips, tongue, or throat.

Call your doctor at once if your child has:

  • jaundice (yellowing of the skin or eyes); or

  • easy bruising, unusual bleeding, purple or red spots under your skin.

Common side effects of onasemnogene abeparvovec may include:

  • vomiting; or

  • abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Onasemnogene abeparvovec (zolgensma) Side Effects

What other drugs will affect Onasemnogene abeparvovec (zolgensma)?

Other drugs may affect onasemnogene abeparvovec, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your child's current medicines and any medicine the child starts or stops using.

More about Onasemnogene abeparvovec (zolgensma) (Onasemnogene abeparvovec (zolgensma) [ on-a-sem-noe-jeen-a-be-par-voe-vek ])

Dosage information
Onasemnogene abeparvovec (zolgensma) Side Effects
During pregnancy
Drug images
Side effects
Drug class: Miscellaneous uncategorized agents

Related treatment guides

Spinal Muscular Atrophy
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by